Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210714051888N1Phase 2Completed
Phase 2, randomised trial in agitation comparing Succinylcholine with Rocuronium (2 arms). Primary endpoint: Rate of emergence agitation. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210714051888N1.